Review Article
The Epidemiology of COVID-19 Vaccine-Induced Myocarditis
Table 5
Summary of management of COVID-19 vaccine-induced myocarditis.
| Clinical presentation | Treatment |
| Chest pain | Initial evaluation using ECG, cardiac troponin, and inflammatory marker levels [114] |
| Arrhythmias | Guideline-directed therapy based on arrhythmia type [115] |
| Heart failure with reduced ejection fraction | Angiotensin-converting enzyme inhibitors | Angiotensin receptor blockers | Beta-blockers | Sodium-glucose cotransporter 2 inhibitors | Mineralocorticoid receptor antagonists [115] |
| Fulminant myocarditis-cardiogenic shock | Short-term corticosteroids | Mechanical circulatory support in left ventricular dysfunction [123, 124] |
|
|